CLINICAL AND IMMUNOLOGICAL FEATURES IN ACUTE RESPIRATORY-VIRAL INFECTIONS IN CHILDREN WITH BRONCHIAL ASTHMA


如何引用文章

全文:

详细

Aim. To study the immune status during acute respiratory viral infections (ARVI) in children with bronchial asthma (AD). Materials and methods. We examined 96 children aged 3 to 7 years during the development of ARVI. At the same time, 62 children (the main group) suffered from AD, 34 - did not have a history of allergy and constituted a comparison group. The control group included 20 healthy children of a similar age. The levels of interferons a and g, interleukins (IL)-4, IL-5, IL-13, CD3+, CD4+, CD8+, CD22+, immunoglobulins (Ig) A, M, G, E were determined in all patients. Results. It was found that acute respiratory viral infections in children with AD are characterized by a complicated and torpid course, an increase in the duration of the main syndromes and the overall duration of the disease (in the main group 15.47±0.56 days, in the comparison group - 9.35±0.74 days; p<0.001). The immune status of children with AD during ARVI is characterized by a significant (p<0.05) lower relative content of T lymphocytes (CD3+) in the blood, an increase in the level of total IgE and a decrease in the concentration of serum IgA in all periods of ARVI. Conclusion. The immune status of children with AD during the period of acute respiratory viral infections is characterized by inhibition of both cellular and humoral immunity, which persists at the time of clinical recovery.

全文:

受限制的访问

作者简介

Irina Melnikova

Mechnikov North-Western State Medical University; Saint Petersburg State Research Institute of Phthisiopulmonology

Email: melnikovai@yandex.ru

Vladimir Buryak

Mechnikov North-Western State Medical University

Mariia Dudko

Children's City Polyclinic №35

Svetlana Melnik

Mechnikov North-Western State Medical University; Saint Petersburg State Research Institute of Phthisiopulmonology

Nina Batrachenko

Saint Petersburg State Research Institute of Phthisiopulmonology

参考

  1. Morice AH, Millqvist E, Bieksiene K et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J 2019; pii: 1901136. doi: 10.1183/13993003.01136-2019
  2. Global Strategy for Asthma Management and Prevention 2015 (update). The GINA reports are. Mode of access: www.ginasthma.org
  3. Булгакова В.А. Модификация терапии бронхиальной астмы. Возможности повышения эффективности лечения вирус-индуцированной астмы у детей. Фарматека. 2015; 4: 6-12. @@Bulgakova V.A. Modifikatsiia terapii bronkhial'noi astmy. Vozmozhnosti povysheniia effektivnosti lecheniia virus-indutsirovannoi astmy u detei. Farmateka. 2015; 4: 6-12 (in Russian).
  4. Романцов М.Г., Мельникова И.Ю. Часто болеющие дети: актуальная проблема педиатрии. Advances Curr Natural Sci 2014; 10: 16-8. @@Romantsov M.G., Mel'nikova I.Iu. Chasto boleiushchie deti: aktual'naia problema pediatrii. Advances Curr Natural Sci 2014; 10: 16-8 (in Russian)
  5. Лещенко И.В. Контроль над бронхиальной астмой: актуальная проблема и ее решение в реальной клинической практике. Пульмонология. 2018; 29 (3). @@Leshchenko I.V. Kontrol' nad bronkhial'noi astmoi: aktual'naia problema i ee reshenie v real'noi klinicheskoi praktike. Pul'monologiia. 2018; 29 (3) (in Russian).
  6. Inoue Y, Shimojo N. Epidemiology of virus-induced wheezing/asthma in children. Front Microbiol 2013; 4: 391.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Consilium Medicum, 2020

Creative Commons License
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 74329 от 19.11.2018 г.